Daiwa Securities Group Inc. Bausch Health Companies Inc. Transaction History

Daiwa Securities Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$18.89 - $31.89 $112,489 - $189,904	-5,955 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$20.88 - $25.66 $384,943 - $473,067	-18,436 Reduced 75.59%	5,955 $130,000
Q2 2019 Jul 24, 2019	SELL	$20.52 - $26.45 $99,316 - $128,018	-4,840 Reduced 16.56%	24,391 $615,000
Q1 2019 Apr 26, 2019	SELL	$20.23 - $26.29 $331,569 - $430,893	-16,390 Reduced 35.93%	29,231 $722,000
Q4 2018 Feb 05, 2019	SELL	$17.64 - $28.32 $1.03 Million - $1.65 Million	-58,135 Reduced 56.03%	45,621 $843,000
Q3 2018 Nov 01, 2018	BUY	$20.64 - $25.67 $2.14 Million - $2.66 Million	103,756 New	103,756 $2.66 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.78B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.